1-(4-Bromophenyl)-4,5-diphenyl-2-(1 H -pyrrol-2-yl)-1 H -imidazole

Key Points

• The compound exhibits notable anticancer activity along with antibiotic and antifungal properties, indicating its potential in medical applications.
• Crystallization occurs in the triclinic P1 space group, demonstrating a complex molecular arrangement that enhances its effectiveness.
• Key interactions within the structure include N—H...Br and C—H...π, which may contribute to its biological activity and stability.
• Further exploration of the compound's properties is necessary to fully understand its therapeutic potential in clinical settings.